Intraocular Bevacizumab Reverses Radiation-Induced Retinopathy

Wednesday, July 11, 2007

Comments

Reuters Health

Intravitreal injections of bevacizumab (Avastin; Genentech) decrease maculopathy and stop the vision loss caused by ophthalmic radiation treatment, according to clinicians at the New York Eye Cancer Center.

Full Story

All of the following drugs are FDA approved for the treatment of predominantly classic subfoveal CNV in patients with neovascular AMD except for which one?
1. Pegaptanib sodium (Macugen)
2. Verteporfin (Visudyne PDT)
3. Ranibizumab (Lucentis)
4. Bevacizumab (Avastin)
5. All of the above
Check The Answer

CareCloud Charts For Ophthalmology
Get all of the tools you need to deliver... view product
3nethra classic Ophthalmic Imaging Device
The 3nethra classic is a compact, ... view product

View all Featured Products »

Keep up with our latest articles, news and events. Plus, get special offers and more delivered to your inbox.

Like us
on Facebook Follow us
on Twitter

OphthalmologyWeb wants to hear from you. Submit your case studies, clinical pearls, practice management tips, editorial, or other manuscripts.

Learn more about writing for us

AdGlare Leaderboard

Intraocular Bevacizumab Reverses Radiation-Induced Retinopathy

Comments

Quick Quiz

All of the following drugs are FDA approved for the treatment of predominantly classic subfoveal CNV in patients with neovascular AMD except for which one?

AdGlare RMR Ad

Featured Products

CareCloud Charts For Ophthalmology

3nethra classic Ophthalmic Imaging Device

Follow OphthalmologyWeb

AdGlare RMR2

Write for Us